| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 59.0954 | 64 |
| GSM780708 | Untreated after 4 days (C2_1) | 59.2476 | 64 |
| GSM780709 | Untreated after 4 days (C3_1) | 66.1722 | 68 |
| GSM780719 | Untreated after 4 days (C1_2) | 51.8602 | 54 |
| GSM780720 | Untreated after 4 days (C2_2) | 55.0633 | 60 |
| GSM780721 | Untreated after 4 days (C3_2) | 51.1222 | 52 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 58.9957 | 64 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 59.9431 | 64 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 53.6904 | 57 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 56.3374 | 61 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 50.6315 | 50 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 54.7992 | 59 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 48.8963 | 45 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 64.7113 | 67 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 54.1358 | 58 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 55.6296 | 60 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 51.4688 | 53 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 61.9347 | 66 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 58.8257 | 64 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 52.7905 | 56 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 61.1306 | 65 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 54.5408 | 59 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 51.1148 | 52 |